BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24247253)

  • 1. Cell division cycle-associated protein 1 overexpression is essential for the malignant potential of colorectal cancers.
    Kobayashi Y; Takano A; Miyagi Y; Tsuchiya E; Sonoda H; Shimizu T; Okabe H; Tani T; Fujiyama Y; Daigo Y
    Int J Oncol; 2014 Jan; 44(1):69-77. PubMed ID: 24247253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.
    Kaneko N; Miura K; Gu Z; Karasawa H; Ohnuma S; Sasaki H; Tsukamoto N; Yokoyama S; Yamamura A; Nagase H; Shibata C; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1235-40. PubMed ID: 19878654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
    Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of osteoprotegerin expression in human colorectal cancer.
    Tsukamoto S; Ishikawa T; Iida S; Ishiguro M; Mogushi K; Mizushima H; Uetake H; Tanaka H; Sugihara K
    Clin Cancer Res; 2011 Apr; 17(8):2444-50. PubMed ID: 21270110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
    Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
    Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
    Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
    J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of UNC5B expression in colorectal cancer.
    Okazaki S; Ishikawa T; Iida S; Ishiguro M; Kobayashi H; Higuchi T; Enomoto M; Mogushi K; Mizushima H; Tanaka H; Uetake H; Sugihara K
    Int J Oncol; 2012 Jan; 40(1):209-16. PubMed ID: 21922135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
    Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
    Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
    Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
    Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer.
    Melling N; Muth J; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
    Diagn Pathol; 2015 Jul; 10():125. PubMed ID: 26208856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion.
    Lin BR; Huang MT; Chen ST; Jeng YM; Li YJ; Liang JT; Lee PH; Chang KJ; Chang CC
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S385-94. PubMed ID: 21681381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of EGFL8: a novel prognostic biomarker for patients with colorectal cancer.
    Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2011 Jun; 31(6):2249-54. PubMed ID: 21737648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of aminoacylase 1 is associated with colorectal cancer progression.
    Shi H; Hayes MT; Kirana C; Miller RJ; Keating JP; Stubbs RS
    Hum Pathol; 2013 Jun; 44(6):1089-97. PubMed ID: 23317546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.